Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Susceptibility to Viral Infections v0.117 | IL27RA | Ain Roesley Marked gene: IL27RA as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.117 | IL27RA | Ain Roesley Gene: il27ra has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.117 | IL27RA | Ain Roesley Classified gene: IL27RA as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.117 | IL27RA | Ain Roesley Gene: il27ra has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.116 | IL27RA |
Ain Roesley gene: IL27RA was added gene: IL27RA was added to Susceptibility to Viral Infections. Sources: Literature Mode of inheritance for gene: IL27RA was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: IL27RA were set to 38509369 Phenotypes for gene: IL27RA were set to Epstein-Barr virus infection MONDO:0005111 , IL27RA-related Review for gene: IL27RA was set to AMBER gene: IL27RA was marked as current diagnostic Added comment: 3 children from 2 families with severe acute EBV infection. fam1: homozygous for p.(Gln96*) (NMD-pred) fam2: chet for p.(Arg446Gly) and c.1142-2A>C the splice variant in fam2 was found to to result in an in-frame deletion p.(Gln381_Ala395del) the missense in fam2 is hypothesised to be a hypomorphic allele: - out of 15 Homs in the Finnish database, 2 had hospital diagnoses of EBV IM - expression of this variant on its own results in a weak but detectable IL-27RA expression associated with significant increase in STAT1/3 phosphorus in response to IL-27 stimulation borderline amber/green due to functional studies performed Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.115 | PLCG2 | Zornitza Stark Marked gene: PLCG2 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.115 | PLCG2 | Zornitza Stark Gene: plcg2 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.115 | PLCG2 | Zornitza Stark Phenotypes for gene: PLCG2 were changed from Susceptibility to herpes virus to Hereditary susceptibility to infections, MONDO:0015979, PLCG2-related; Susceptibility to herpes virus | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.114 | PLCG2 | Zornitza Stark Classified gene: PLCG2 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.114 | PLCG2 | Zornitza Stark Gene: plcg2 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.113 | PLCG2 |
Peter McNaughton gene: PLCG2 was added gene: PLCG2 was added to Susceptibility to Viral Infections. Sources: Literature Mode of inheritance for gene: PLCG2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: PLCG2 were set to PMID: 37714437 Phenotypes for gene: PLCG2 were set to Susceptibility to herpes virus Review for gene: PLCG2 was set to GREEN Added comment: Patients from two unrelated nonconsanguineous families with PLCG2 haploinsufficiency, characterized by herpesvirus infections and reduced NK cell killing. A mouse model of haploinsufficiency was validated by comparing wildtype (Plcg2+/+) and Plcg2+/- mice, NK cell maturation was increased in Plcg2+/- mice, NK1.1-induced calcium flux was attenuated in Plcg2+/- NK cells, NK cell killing of RMA-S target cells was inhibited in Plcg2+/- mice Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.113 | CD70 | Zornitza Stark Tag treatable tag was added to gene: CD70. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.113 | TNFRSF9 | Zornitza Stark Marked gene: TNFRSF9 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.113 | TNFRSF9 | Zornitza Stark Gene: tnfrsf9 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.113 | TNFRSF9 | Zornitza Stark Phenotypes for gene: TNFRSF9 were changed from EBV associated lymphoproliferative disease to Immunodeficiency 109 with lymphoproliferation, MIM# 620282 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.112 | TNFRSF9 | Zornitza Stark Classified gene: TNFRSF9 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.112 | TNFRSF9 | Zornitza Stark Gene: tnfrsf9 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.111 | RIPK3 | Zornitza Stark Marked gene: RIPK3 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.111 | RIPK3 | Zornitza Stark Gene: ripk3 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.111 | RIPK3 | Zornitza Stark Phenotypes for gene: RIPK3 were changed from Recurrent HSV encephalitis to Hereditary susceptibility to infections, MONDO:0015979, RIPK3-related; Recurrent HSV encephalitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.110 | RIPK3 | Zornitza Stark Classified gene: RIPK3 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.110 | RIPK3 | Zornitza Stark Gene: ripk3 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.109 | TNFRSF9 |
Peter McNaughton gene: TNFRSF9 was added gene: TNFRSF9 was added to Susceptibility to Viral Infections. Sources: Literature Mode of inheritance for gene: TNFRSF9 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TNFRSF9 were set to PMID: 37144041 Phenotypes for gene: TNFRSF9 were set to EBV associated lymphoproliferative disease Review for gene: TNFRSF9 was set to GREEN Added comment: Patient with novel biallelic variants (c.208 + 1>AT and p.T151K) with EBV induced lymphoproliferative disease and chronic active EBV. Multiple previous patients reported with EBV associated disease (table1). Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.109 | RIPK3 |
Peter McNaughton gene: RIPK3 was added gene: RIPK3 was added to Susceptibility to Viral Infections. Sources: Literature Mode of inheritance for gene: RIPK3 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: RIPK3 were set to PMID: 37083451 Phenotypes for gene: RIPK3 were set to Recurrent HSV encephalitis Review for gene: RIPK3 was set to AMBER Added comment: Single female patient with independent episodes of HSE at 6 and 17 months of age and with autoimmune encephalitis 1 month after the second episode of HSE with two heterozygous mutations of RIPK3 predicted to be loss of function (pLOF): p. Arg422* (c.1264 C > T, MAF 0.001568, CADD 35) and p. Pro493fs9* (c.1475 C > CC, MAF 0.002611, CADD 24.2). Extensive supportive functional data including RIPK3 knockout human pluripotent stem cell–derived cortical neurons. Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.109 | STAT2 |
Peter McNaughton changed review comment from: Susceptibility to virus including disseminated vaccine strain measles.; to: Susceptibility to virus including disseminated vaccine strain measles. Additional publication PMID: 36976641 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.109 | STAT2 | Peter McNaughton changed review comment from: Susceptibility to virus including disseminated vaccine strain measles.; to: Susceptibility to virus including disseminated vaccine strain measles. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.109 |
Zornitza Stark HPO terms changed from to Recurrent viral infections, HP:0004429; Severe viral infection, HP:0031691 List of related panels changed from to Recurrent viral infections; HP:0004429; Severe viral infection; HP:0031691 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.108 | IRF7 | Zornitza Stark Publications for gene: IRF7 were set to 25814066; 15800576 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.107 | IRF7 | Zornitza Stark Classified gene: IRF7 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.107 | IRF7 | Zornitza Stark Gene: irf7 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.106 | IRF7 | Zornitza Stark edited their review of gene: IRF7: Added comment: Additional individuals reported PMIDs 35986347, 35670811: total of 7; Changed rating: GREEN; Changed publications: 25814066, 15800576, 35986347, 35670811 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.106 | TMC8 | Peter McNaughton reviewed gene: TMC8: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 34459021, 28646613, 12426567; Phenotypes: Epidermodysplasia verruciformis 2; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.106 | TMC6 | Peter McNaughton reviewed gene: TMC6: Rating: ; Mode of pathogenicity: None; Publications: PMID: 12426567, PMID 15042430; Phenotypes: Epidermodysplasia veruciformis; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.106 | CXCR4 | Peter McNaughton reviewed gene: CXCR4: Rating: GREEN; Mode of pathogenicity: None; Publications: 12692554; Phenotypes: WHIM syndrome; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.106 | TLR3 | Zornitza Stark Marked gene: TLR3 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.106 | TLR3 | Zornitza Stark Gene: tlr3 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.106 | TLR3 | Zornitza Stark Phenotypes for gene: TLR3 were changed from to {Immunodeficiency 83, susceptibility to viral infections}, MIM# 613002 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.105 | TLR3 | Zornitza Stark Publications for gene: TLR3 were set to | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.104 | TLR3 | Zornitza Stark Mode of inheritance for gene: TLR3 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.103 | TLR3 | Zornitza Stark reviewed gene: TLR3: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: {Immunodeficiency 83, susceptibility to viral infections}, MIM# 613002; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.103 | TICAM1 | Zornitza Stark Marked gene: TICAM1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.103 | TICAM1 | Zornitza Stark Gene: ticam1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.103 | TICAM1 | Zornitza Stark Phenotypes for gene: TICAM1 were changed from to {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}, MIM# 614850 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.102 | TICAM1 | Zornitza Stark Publications for gene: TICAM1 were set to | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.101 | TICAM1 | Zornitza Stark edited their review of gene: TICAM1: Added comment: Two each with bi-allelic and mono-allelic variants (total of 4 patients), plus functional data.; Changed publications: 22105173, 26513235 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.101 | STAT2 | Peter McNaughton reviewed gene: STAT2: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 23391734, PMID: 34448086; Phenotypes: Susceptibility to viral disease; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.101 | TICAM1 | Zornitza Stark Mode of inheritance for gene: TICAM1 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.100 | TICAM1 | Zornitza Stark reviewed gene: TICAM1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}, MIM# 614850; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.100 | STAT1 | Zornitza Stark Marked gene: STAT1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.100 | STAT1 | Zornitza Stark Gene: stat1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.100 | STAT1 | Zornitza Stark Phenotypes for gene: STAT1 were changed from to Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, MIM# 613796 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.99 | STAT1 | Zornitza Stark Publications for gene: STAT1 were set to | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.98 | STAT1 | Zornitza Stark Mode of inheritance for gene: STAT1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.97 | STAT1 | Zornitza Stark reviewed gene: STAT1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, MIM# 613796; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.97 | TBK1 | Zornitza Stark Marked gene: TBK1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.97 | TBK1 | Zornitza Stark Gene: tbk1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.97 | TBK1 | Zornitza Stark Phenotypes for gene: TBK1 were changed from to Hereditary predisposition to infections, MONDO:0015979, TBK1-related | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.96 | TBK1 | Zornitza Stark Publications for gene: TBK1 were set to | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.95 | TBK1 | Zornitza Stark Mode of pathogenicity for gene: TBK1 was changed from Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments to Other | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.95 | TBK1 | Zornitza Stark Mode of pathogenicity for gene: TBK1 was changed from to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.94 | TLR3 | Peter McNaughton reviewed gene: TLR3: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 17872438, PMID: 25339207; Phenotypes: Herpes encephalitis; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.94 | TBK1 | Zornitza Stark Mode of inheritance for gene: TBK1 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.93 | TBK1 | Zornitza Stark reviewed gene: TBK1: Rating: GREEN; Mode of pathogenicity: Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments; Publications: ; Phenotypes: Hereditary predisposition to infections, MONDO:0015979, TBK1-related; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.93 | TICAM1 | Peter McNaughton reviewed gene: TICAM1: Rating: ; Mode of pathogenicity: None; Publications: PMID: 22105173; Phenotypes: Herpes encephalitis; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.93 | STAT1 | Peter McNaughton reviewed gene: STAT1: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 12590259, PMID: 16585605; Phenotypes: Susceptibility to mycobacterial disease, severe viral disease; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.93 | TBK1 | Peter McNaughton reviewed gene: TBK1: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 22851595; Phenotypes: Susceptibility to herpes encephalitis; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.93 | MCM10 | Zornitza Stark Publications for gene: MCM10 were set to 32865517 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.92 | MCM10 | Zornitza Stark Classified gene: MCM10 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.92 | MCM10 | Zornitza Stark Gene: mcm10 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.91 | MCM10 | Peter McNaughton reviewed gene: MCM10: Rating: AMBER; Mode of pathogenicity: None; Publications: PMID: 33712616; Phenotypes: ; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.91 | CD28 | Zornitza Stark Marked gene: CD28 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.91 | CD28 | Zornitza Stark Gene: cd28 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.91 | CD28 | Zornitza Stark Classified gene: CD28 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.91 | CD28 | Zornitza Stark Gene: cd28 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.90 | CD28 | Zornitza Stark reviewed gene: CD28: Rating: AMBER; Mode of pathogenicity: None; Publications: 34214472; Phenotypes: Hereditary predisposition to infections, MONDO:0015979, CD28-related; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.90 | CD28 | Zornitza Stark Phenotypes for gene: CD28 were changed from Hereditary predisposition to infections, MONDO:0015979, CD28-related; isolated susceptibility to cutaneous α- and γ-HPVs to Hereditary predisposition to infections, MONDO:0015979, CD28-related; isolated susceptibility to cutaneous α- and γ-HPVs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.89 | CD28 | Zornitza Stark Phenotypes for gene: CD28 were changed from isolated susceptibility to cutaneous α- and γ-HPVs to Hereditary predisposition to infections, MONDO:0015979, CD28-related; isolated susceptibility to cutaneous α- and γ-HPVs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.88 | CD28 | Zornitza Stark Classified gene: CD28 as Red List (low evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.88 | CD28 | Zornitza Stark Gene: cd28 has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.87 | IFNAR2 | Zornitza Stark Publications for gene: IFNAR2 were set to 26424569 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.86 | IFNAR2 | Zornitza Stark Classified gene: IFNAR2 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.86 | IFNAR2 | Zornitza Stark Gene: ifnar2 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.85 | IFNAR1 | Zornitza Stark Phenotypes for gene: IFNAR1 were changed from Severe disease caused by Yellow Fever vaccine and Measles vaccine to Immunodeficiency 106, susceptibility to viral infections, MIM# 619935; Severe disease caused by Yellow Fever vaccine and Measles vaccine | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.84 | IFNAR1 | Zornitza Stark Classified gene: IFNAR1 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.84 | IFNAR1 | Zornitza Stark Gene: ifnar1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.83 | CD28 |
Peter McNaughton gene: CD28 was added gene: CD28 was added to Susceptibility to Viral Infections. Sources: Literature Mode of inheritance for gene: CD28 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: CD28 were set to PMID: 34214472 Phenotypes for gene: CD28 were set to isolated susceptibility to cutaneous α- and γ-HPVs Review for gene: CD28 was set to RED Added comment: Rare homozygous CD28 variant segregates with severe verrucosis in three relatives and supportive functional data. Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.83 | IFNAR2 | Peter McNaughton reviewed gene: IFNAR2: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 35442417; Phenotypes: Severe viral disease; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.83 | IFNAR1 | Peter McNaughton reviewed gene: IFNAR1: Rating: GREEN; Mode of pathogenicity: None; Publications: PMID: 35442418; Phenotypes: Severe Viral disease; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.83 | POLR3F | Zornitza Stark Phenotypes for gene: POLR3F were changed from Severe VZV infection to Immunodeficiency 101 (varicella zoster virus-specific), MIM# 619872 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.82 | POLR3F | Zornitza Stark edited their review of gene: POLR3F: Changed phenotypes: Immunodeficiency 101 (varicella zoster virus-specific), MIM# 619872 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.82 | ZNFX1 | Zornitza Stark Phenotypes for gene: ZNFX1 were changed from Multisystem inflammation; susceptibility to viral infections to Immunodeficiency 91 and hyperinflammation, MIM# 619644 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.81 | ZNFX1 | Zornitza Stark edited their review of gene: ZNFX1: Changed phenotypes: Immunodeficiency 91 and hyperinflammation, MIM# 619644 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.81 | UNC93B1 | Zornitza Stark Marked gene: UNC93B1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.81 | UNC93B1 | Zornitza Stark Gene: unc93b1 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.81 | UNC93B1 | Zornitza Stark Phenotypes for gene: UNC93B1 were changed from to Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.80 | UNC93B1 | Zornitza Stark Publications for gene: UNC93B1 were set to | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.79 | UNC93B1 | Zornitza Stark Mode of inheritance for gene: UNC93B1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.78 | UNC93B1 | Zornitza Stark Classified gene: UNC93B1 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.78 | UNC93B1 | Zornitza Stark Gene: unc93b1 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.77 | UNC93B1 | Zornitza Stark reviewed gene: UNC93B1: Rating: AMBER; Mode of pathogenicity: None; Publications: 16973841, 29768176; Phenotypes: Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.77 | IFIH1 | Sarah Pantaleo reviewed gene: IFIH1: Rating: GREEN; Mode of pathogenicity: None; Publications: 34185153; Phenotypes: Inflammatory Bowel Disease; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.77 | DBR1 | Zornitza Stark Phenotypes for gene: DBR1 were changed from Viral infections of the brainstem to {Encephalitis, acute, infection (viral)-induced, susceptibility to, 11}, MIM# 619441; Viral infections of the brainstem | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.76 | DBR1 | Zornitza Stark edited their review of gene: DBR1: Changed phenotypes: {Encephalitis, acute, infection (viral)-induced, susceptibility to, 11}, MIM# 619441, Viral infections of the brainstem | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.76 | SNORA31 | Zornitza Stark Phenotypes for gene: SNORA31 were changed from Susceptibility to HSV1 encephalitis to {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}, MIM# 619396 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.75 | SNORA31 | Zornitza Stark edited their review of gene: SNORA31: Changed phenotypes: {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}, MIM# 619396 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.75 | MCM10 | Zornitza Stark Phenotypes for gene: MCM10 were changed from Susceptibility to CMV to Immunodeficiency-80 with or without congenital cardiomyopathy (IMD80), MIM#619313; Susceptibility to CMV | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.74 | MCM10 | Zornitza Stark edited their review of gene: MCM10: Changed phenotypes: Immunodeficiency-80 with or without congenital cardiomyopathy (IMD80), MIM#619313, Susceptibility to CMV | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.74 | ZNFX1 | Zornitza Stark Marked gene: ZNFX1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.74 | ZNFX1 | Zornitza Stark Gene: znfx1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.74 | ZNFX1 | Zornitza Stark Classified gene: ZNFX1 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.74 | ZNFX1 | Zornitza Stark Gene: znfx1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.73 | ZNFX1 |
Zornitza Stark gene: ZNFX1 was added gene: ZNFX1 was added to Susceptibility to Viral Infections. Sources: Literature Mode of inheritance for gene: ZNFX1 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ZNFX1 were set to 33872655 Phenotypes for gene: ZNFX1 were set to Multisystem inflammation; susceptibility to viral infections Review for gene: ZNFX1 was set to GREEN Added comment: 15 individuals from 8 families reported. Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.72 | MCM10 | Zornitza Stark edited their review of gene: MCM10: Changed mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.72 | CD4 | Zornitza Stark Phenotypes for gene: CD4 were changed from Absence of CD4+ T cells; exuberant, relapsing, treatment-refractory warts to Immunodeficiency 79, MIM# 619238; Absence of CD4+ T cells; exuberant, relapsing, treatment-refractory warts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.71 | CD4 | Zornitza Stark Publications for gene: CD4 were set to 31781092 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.70 | CD4 | Zornitza Stark Classified gene: CD4 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.70 | CD4 | Zornitza Stark Gene: cd4 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.69 | CD4 |
Zornitza Stark changed review comment from: Single individual reported, functional data, emerging gene. Sources: Literature; to: Two individuals reported, functional data. Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.69 | CD4 | Zornitza Stark edited their review of gene: CD4: Changed rating: GREEN | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.69 | CD4 | Zornitza Stark edited their review of gene: CD4: Changed publications: 31781092, 33471124 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.69 | CD4 | Zornitza Stark edited their review of gene: CD4: Changed phenotypes: Immunodeficiency 79, MIM# 619238, Absence of CD4+ T cells, exuberant, relapsing, treatment-refractory warts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.69 | TAOK2 | Bryony Thompson Marked gene: TAOK2 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.69 | TAOK2 | Bryony Thompson Gene: taok2 has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.69 | TAOK2 |
Bryony Thompson gene: TAOK2 was added gene: TAOK2 was added to Susceptibility to Viral Infections. Sources: Other Mode of inheritance for gene: TAOK2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TAOK2 were set to 28385331 Phenotypes for gene: TAOK2 were set to Generalized verrucosis; abnormal T cell activation Review for gene: TAOK2 was set to RED Added comment: A single consanguineous family with a homozygous missense (p.R700C), and some assays on patient fibroblasts. Sources: Other |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.68 | TLR7 | Zornitza Stark Mode of inheritance for gene: TLR7 was changed from BIALLELIC, autosomal or pseudoautosomal to X-LINKED: hemizygous mutation in males, biallelic mutations in females | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.67 | TLR7 | Zornitza Stark edited their review of gene: TLR7: Changed mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.67 | MCM10 | Zornitza Stark Marked gene: MCM10 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.67 | MCM10 | Zornitza Stark Gene: mcm10 has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.67 | MCM10 | Zornitza Stark Mode of inheritance for gene: MCM10 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.66 | MCM10 |
Zornitza Stark gene: MCM10 was added gene: MCM10 was added to Susceptibility to Viral Infections. Sources: Literature Mode of inheritance for gene: MCM10 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: MCM10 were set to 32865517 Phenotypes for gene: MCM10 were set to Susceptibility to CMV Review for gene: MCM10 was set to RED Added comment: Compound heterozygous variants in minichromosomal maintenance complex member 10 (MCM10) reported as a cause of NK-cell deficiency in a child with fatal susceptibility to CMV. Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.65 | TLR7 | Zornitza Stark Marked gene: TLR7 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.65 | TLR7 | Zornitza Stark Gene: tlr7 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.65 | TLR7 | Zornitza Stark Classified gene: TLR7 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.65 | TLR7 | Zornitza Stark Gene: tlr7 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.64 | TLR7 |
Zornitza Stark gene: TLR7 was added gene: TLR7 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: TLR7 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TLR7 were set to 32706371 Phenotypes for gene: TLR7 were set to Immunodeficiency 74, COVID19-related, X-linked, MIM# 301051 Review for gene: TLR7 was set to GREEN Added comment: Four affected individuals from two unrelated families and some functional data. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.61 | FUT2 | Zornitza Stark Marked gene: FUT2 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.61 | FUT2 | Zornitza Stark Gene: fut2 has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.61 | FUT2 |
Zornitza Stark gene: FUT2 was added gene: FUT2 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: FUT2 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: FUT2 were set to Norwalk virus infection, resistance to Review for gene: FUT2 was set to RED Added comment: Not a monogenic condition, but individuals homozygous for p.(Trp143Ter) are resistant to norovirus infection. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.60 | CCR5 | Zornitza Stark Marked gene: CCR5 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.60 | CCR5 | Zornitza Stark Gene: ccr5 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.60 | CCR5 | Zornitza Stark Classified gene: CCR5 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.60 | CCR5 | Zornitza Stark Gene: ccr5 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.59 | CCR5 |
Zornitza Stark gene: CCR5 was added gene: CCR5 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: CCR5 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: CCR5 were set to {Hepatitis C virus, resistance to} 609532; {HIV infection, susceptibility/resistance to}; {West nile virus, susceptibility to}MIM# 610379 Review for gene: CCR5 was set to GREEN Added comment: Particular SNVs in this gene are well established as conferring resistance to certain viral infections, notably HIV. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.58 | TNFRSF4 | Zornitza Stark Marked gene: TNFRSF4 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.58 | TNFRSF4 | Zornitza Stark Gene: tnfrsf4 has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.58 | TNFRSF4 |
Zornitza Stark gene: TNFRSF4 was added gene: TNFRSF4 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: TNFRSF4 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TNFRSF4 were set to 23897980 Phenotypes for gene: TNFRSF4 were set to Immunodeficiency 16, MIM# 615593 Review for gene: TNFRSF4 was set to RED Added comment: Single case report in an individual with childhood-onset Kaposi's sarcoma (susceptibility to HHV8), homozygous missense variant, plausible biological candidate but direct evidence of causality limited. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.57 | MAGT1 | Zornitza Stark Marked gene: MAGT1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.57 | MAGT1 | Zornitza Stark Gene: magt1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.57 | MAGT1 | Zornitza Stark Classified gene: MAGT1 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.57 | MAGT1 | Zornitza Stark Gene: magt1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.56 | MAGT1 |
Zornitza Stark gene: MAGT1 was added gene: MAGT1 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: MAGT1 was set to X-LINKED: hemizygous mutation in males, biallelic mutations in females Publications for gene: MAGT1 were set to 21796205; 24550228; 25504528 Phenotypes for gene: MAGT1 were set to Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, MIM# 300853 Review for gene: MAGT1 was set to GREEN Added comment: Multiple unrelated families reported. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.55 | TRIM69 | Zornitza Stark Marked gene: TRIM69 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.55 | TRIM69 | Zornitza Stark Gene: trim69 has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.55 | TRIM69 |
Zornitza Stark gene: TRIM69 was added gene: TRIM69 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: TRIM69 was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal Publications for gene: TRIM69 were set to 22105173 Phenotypes for gene: TRIM69 were set to Susceptibility to herpes simplex encephalitis Review for gene: TRIM69 was set to RED Added comment: One individual with bi-allelic and one individual with mono-allelic variants in this gene described. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.54 | CD4 | Zornitza Stark Marked gene: CD4 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.54 | CD4 | Zornitza Stark Gene: cd4 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.54 | CD4 | Zornitza Stark Classified gene: CD4 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.54 | CD4 | Zornitza Stark Gene: cd4 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.53 | CD4 |
Zornitza Stark gene: CD4 was added gene: CD4 was added to Susceptibility to Viral Infections. Sources: Literature Mode of inheritance for gene: CD4 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: CD4 were set to 31781092 Phenotypes for gene: CD4 were set to Absence of CD4+ T cells; exuberant, relapsing, treatment-refractory warts Review for gene: CD4 was set to AMBER Added comment: Single individual reported, functional data, emerging gene. Sources: Literature |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.52 | POLR3C | Zornitza Stark Marked gene: POLR3C as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.52 | POLR3C | Zornitza Stark Gene: polr3c has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.52 | IL18BP | Zornitza Stark Marked gene: IL18BP as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.52 | IL18BP | Zornitza Stark Gene: il18bp has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.52 | NOS2 | Zornitza Stark Marked gene: NOS2 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.52 | NOS2 | Zornitza Stark Gene: nos2 has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.52 | NOS2 |
Zornitza Stark gene: NOS2 was added gene: NOS2 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: NOS2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: NOS2 were set to 31995689 Phenotypes for gene: NOS2 were set to Disseminated CMV disease Review for gene: NOS2 was set to RED Added comment: Single individual reported with progressive, fatal CMV disease and homozygous LoF variant in NOS2. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.51 | CD70 | Zornitza Stark Marked gene: CD70 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.51 | CD70 | Zornitza Stark Gene: cd70 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.51 | CD70 | Zornitza Stark Classified gene: CD70 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.51 | CD70 | Zornitza Stark Gene: cd70 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.50 | CD70 |
Zornitza Stark gene: CD70 was added gene: CD70 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: CD70 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: CD70 were set to 28011864; 28011863, Phenotypes for gene: CD70 were set to Lymphoproliferative syndrome 3, MIM# 618261; Host response to EBV Review for gene: CD70 was set to GREEN Added comment: Three unrelated families reported. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.49 | CD27 | Zornitza Stark Marked gene: CD27 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.49 | CD27 | Zornitza Stark Gene: cd27 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.49 | CD27 | Zornitza Stark Classified gene: CD27 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.49 | CD27 | Zornitza Stark Gene: cd27 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.48 | CD27 |
Zornitza Stark gene: CD27 was added gene: CD27 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: CD27 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: CD27 were set to 22801960; 22197273 Phenotypes for gene: CD27 were set to Lymphoproliferative syndrome 2, MIM# 615122; Host response to EBV Review for gene: CD27 was set to GREEN Added comment: At least four families reported. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.47 | ITK | Zornitza Stark Marked gene: ITK as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.47 | ITK | Zornitza Stark Gene: itk has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.47 | ITK | Zornitza Stark Classified gene: ITK as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.47 | ITK | Zornitza Stark Gene: itk has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.46 | ITK |
Zornitza Stark gene: ITK was added gene: ITK was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: ITK was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ITK were set to 19425169; 22289921; 21109689 Phenotypes for gene: ITK were set to Lymphoproliferative syndrome 1, MIM# 613011; EBV- associated B cell lymphoproliferation, lymphoma Review for gene: ITK was set to GREEN Added comment: At least three families reported, abnormal host response to EBV. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.45 | XIAP | Zornitza Stark Marked gene: XIAP as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.45 | XIAP | Zornitza Stark Gene: xiap has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.45 | XIAP | Zornitza Stark Classified gene: XIAP as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.45 | XIAP | Zornitza Stark Gene: xiap has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.44 | XIAP |
Zornitza Stark gene: XIAP was added gene: XIAP was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: XIAP was set to X-LINKED: hemizygous mutation in males, biallelic mutations in females Publications for gene: XIAP were set to 17080092 Phenotypes for gene: XIAP were set to Lymphoproliferative syndrome, X-linked, 2 300635; Host response to EBV Review for gene: XIAP was set to GREEN Added comment: Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.43 | SH2D1A | Zornitza Stark Marked gene: SH2D1A as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.43 | SH2D1A | Zornitza Stark Gene: sh2d1a has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.43 | SH2D1A | Zornitza Stark Classified gene: SH2D1A as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.43 | SH2D1A | Zornitza Stark Gene: sh2d1a has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.42 | SH2D1A |
Zornitza Stark gene: SH2D1A was added gene: SH2D1A was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: SH2D1A was set to X-LINKED: hemizygous mutation in males, biallelic mutations in females Publications for gene: SH2D1A were set to 9771704 Phenotypes for gene: SH2D1A were set to Host response to EBV infection; Lymphoproliferative syndrome, X-linked, 1 308240 Review for gene: SH2D1A was set to GREEN Added comment: Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.41 | NLRP1 | Zornitza Stark Marked gene: NLRP1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.41 | NLRP1 | Zornitza Stark Gene: nlrp1 has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.41 | NLRP1 |
Zornitza Stark gene: NLRP1 was added gene: NLRP1 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: NLRP1 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: NLRP1 were set to 31484767 Phenotypes for gene: NLRP1 were set to Recurrent respiratory papillomatosis Review for gene: NLRP1 was set to RED Added comment: Single family reported with homozygous GoF variants in siblings with recurrent respiratory papillomatosis. Note gene is associated with multiple, mono- and bi-allelic immunological phenotypes. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.40 | CIB1 | Zornitza Stark Marked gene: CIB1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.40 | CIB1 | Zornitza Stark Gene: cib1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.40 | CIB1 | Zornitza Stark Classified gene: CIB1 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.40 | CIB1 | Zornitza Stark Gene: cib1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.39 | CIB1 |
Zornitza Stark gene: CIB1 was added gene: CIB1 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: CIB1 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: CIB1 were set to 30068544 Phenotypes for gene: CIB1 were set to Epidermodysplasia verruciformis 3, MIM# 618267; HPV infections and cancer of the skin Review for gene: CIB1 was set to GREEN Added comment: 24 individuals from six families reported. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.38 | SNORA31 | Zornitza Stark Marked gene: SNORA31 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.38 | SNORA31 | Zornitza Stark Gene: snora31 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.38 | SNORA31 | Zornitza Stark Phenotypes for gene: SNORA31 were changed from Susceptibility to herpes simplex encephalitis to Susceptibility to HSV1 encephalitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.37 | SNORA31 | Zornitza Stark Classified gene: SNORA31 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.37 | SNORA31 | Zornitza Stark Gene: snora31 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.36 | SNORA31 |
Zornitza Stark gene: SNORA31 was added gene: SNORA31 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: SNORA31 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: SNORA31 were set to 31806906 Phenotypes for gene: SNORA31 were set to Susceptibility to herpes simplex encephalitis Review for gene: SNORA31 was set to GREEN Added comment: Five unrelated individuals reported with rare missense variants in this gene, functional data to support susceptibility to herpes simplex encephalitis. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.35 | IL18BP |
Zornitza Stark gene: IL18BP was added gene: IL18BP was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: IL18BP was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: IL18BP were set to 31213488 Phenotypes for gene: IL18BP were set to {?Hepatitis, fulminant viral, susceptibility to} 618549 Review for gene: IL18BP was set to RED Added comment: Single individual reported with homozygous 40bp deletion in this gene and fulminant Hep A hepatitis. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.34 | TRAF3 | Zornitza Stark Marked gene: TRAF3 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.34 | TRAF3 | Zornitza Stark Gene: traf3 has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.34 | TRAF3 | Zornitza Stark Phenotypes for gene: TRAF3 were changed from to {?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}, MIM# 614849 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.33 | TRAF3 | Zornitza Stark Publications for gene: TRAF3 were set to | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.32 | TRAF3 | Zornitza Stark Mode of inheritance for gene: TRAF3 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.31 | TRAF3 | Zornitza Stark Classified gene: TRAF3 as Red List (low evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.31 | TRAF3 | Zornitza Stark Gene: traf3 has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.30 | TRAF3 | Zornitza Stark reviewed gene: TRAF3: Rating: RED; Mode of pathogenicity: None; Publications: 20832341; Phenotypes: {?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}, MIM# 614849; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.30 | IRF7 | Zornitza Stark Marked gene: IRF7 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.30 | IRF7 | Zornitza Stark Gene: irf7 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.30 | IRF7 | Zornitza Stark Phenotypes for gene: IRF7 were changed from to Immunodeficiency 39, MIM# 616345 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.29 | IRF7 | Zornitza Stark Publications for gene: IRF7 were set to | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.28 | IRF7 | Zornitza Stark Mode of inheritance for gene: IRF7 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.27 | IRF7 | Zornitza Stark Classified gene: IRF7 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.27 | IRF7 | Zornitza Stark Gene: irf7 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.26 | IRF7 | Zornitza Stark reviewed gene: IRF7: Rating: AMBER; Mode of pathogenicity: None; Publications: 25814066, 15800576; Phenotypes: Immunodeficiency 39, MIM# 616345; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.26 | FCGR3A | Zornitza Stark Marked gene: FCGR3A as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.26 | FCGR3A | Zornitza Stark Gene: fcgr3a has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.26 | FCGR3A | Zornitza Stark Phenotypes for gene: FCGR3A were changed from to Immunodeficiency 20, MIM# 615707 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.25 | FCGR3A | Zornitza Stark Publications for gene: FCGR3A were set to | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.24 | FCGR3A | Zornitza Stark Mode of inheritance for gene: FCGR3A was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.23 | FCGR3A | Zornitza Stark Classified gene: FCGR3A as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.23 | FCGR3A | Zornitza Stark Gene: fcgr3a has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.22 | FCGR3A | Zornitza Stark reviewed gene: FCGR3A: Rating: AMBER; Mode of pathogenicity: None; Publications: 8874200, 23006327, 8608639; Phenotypes: Immunodeficiency 20, MIM# 615707; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.22 | DBR1 | Zornitza Stark Marked gene: DBR1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.22 | DBR1 | Zornitza Stark Gene: dbr1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.22 | DBR1 | Zornitza Stark Classified gene: DBR1 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.22 | DBR1 | Zornitza Stark Gene: dbr1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.21 | DBR1 |
Zornitza Stark gene: DBR1 was added gene: DBR1 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: DBR1 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: DBR1 were set to 29474921 Phenotypes for gene: DBR1 were set to Viral infections of the brainstem Review for gene: DBR1 was set to GREEN Added comment: Seven individuals from three unrelated families with viral brainstem encephalitis and bi-allelic hypomorphic variants. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.20 | POLR3F | Zornitza Stark Marked gene: POLR3F as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.20 | POLR3F | Zornitza Stark Gene: polr3f has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.20 | POLR3F |
Zornitza Stark gene: POLR3F was added gene: POLR3F was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: POLR3F was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: POLR3F were set to 30211253 Phenotypes for gene: POLR3F were set to Severe VZV infection Review for gene: POLR3F was set to RED Added comment: Missense variant identified in a pair of monozygotic twins. Variant was paternally inherited. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.19 | POLR3C | Zornitza Stark Classified gene: POLR3C as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.19 | POLR3C | Zornitza Stark Gene: polr3c has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.18 | POLR3C |
Zornitza Stark gene: POLR3C was added gene: POLR3C was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: POLR3C was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: POLR3C were set to 28783042 Phenotypes for gene: POLR3C were set to Severe VZV infection Review for gene: POLR3C was set to AMBER Added comment: One individual with POLR3C variant and another individual with both POL3RA and POL3RC variants. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.17 | POLR3A | Zornitza Stark Marked gene: POLR3A as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.17 | POLR3A | Zornitza Stark Gene: polr3a has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.17 | POLR3A | Zornitza Stark Classified gene: POLR3A as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.17 | POLR3A | Zornitza Stark Gene: polr3a has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.16 | POLR3A |
Zornitza Stark gene: POLR3A was added gene: POLR3A was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: POLR3A was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: POLR3A were set to 28783042; 29728610 Phenotypes for gene: POLR3A were set to Severe VZV infection Review for gene: POLR3A was set to AMBER Added comment: Two individuals with mono allelic POLR3A variants and another individual with both POLR3A and a POLR3C variants reported. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.15 | IFIH1 | Zornitza Stark Marked gene: IFIH1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.15 | IFIH1 | Zornitza Stark Gene: ifih1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.15 | IFIH1 | Zornitza Stark Classified gene: IFIH1 as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.15 | IFIH1 | Zornitza Stark Gene: ifih1 has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.14 | IFIH1 |
Zornitza Stark gene: IFIH1 was added gene: IFIH1 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: IFIH1 was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal Publications for gene: IFIH1 were set to 28716935; 29018476 Phenotypes for gene: IFIH1 were set to Severe viral respiratory infections; Rhinovirus and other RNA viruses Review for gene: IFIH1 was set to GREEN Added comment: Three unrelated individuals with mono allelic LoF variants reported from a cohort of children admitted to ICU with severe respiratory infections (PMID:28716935). Another individual with bi-allelic variants and recurrent and prolonged infections also reported (PMID: 29018476) Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.13 | IFNAR2 | Zornitza Stark Marked gene: IFNAR2 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.13 | IFNAR2 | Zornitza Stark Gene: ifnar2 has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.13 | IFNAR2 |
Zornitza Stark gene: IFNAR2 was added gene: IFNAR2 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: IFNAR2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: IFNAR2 were set to 26424569 Phenotypes for gene: IFNAR2 were set to Immunodeficiency 45, MIM# 616669 Review for gene: IFNAR2 was set to RED Added comment: Single individual reported. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.12 | IFNAR1 | Zornitza Stark Marked gene: IFNAR1 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.12 | IFNAR1 | Zornitza Stark Gene: ifnar1 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.12 | IFNAR1 | Zornitza Stark Classified gene: IFNAR1 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.12 | IFNAR1 | Zornitza Stark Gene: ifnar1 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.11 | IFNAR1 |
Zornitza Stark gene: IFNAR1 was added gene: IFNAR1 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: IFNAR1 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: IFNAR1 were set to 31270247 Phenotypes for gene: IFNAR1 were set to Severe disease caused by Yellow Fever vaccine and Measles vaccine Review for gene: IFNAR1 was set to AMBER Added comment: Two unrelated individuals reported with bi-allelic LoF variants, some functional data. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.10 | IRF9 | Zornitza Stark Marked gene: IRF9 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.10 | IRF9 | Zornitza Stark Gene: irf9 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.10 | IRF9 | Zornitza Stark Classified gene: IRF9 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.10 | IRF9 | Zornitza Stark Gene: irf9 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.9 | IRF9 |
Zornitza Stark gene: IRF9 was added gene: IRF9 was added to Susceptibility to Viral Infections. Sources: Expert list Mode of inheritance for gene: IRF9 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: IRF9 were set to 30826365; 30143481 Phenotypes for gene: IRF9 were set to Immunodeficiency 65, susceptibility to viral infections 618648 Review for gene: IRF9 was set to AMBER Added comment: Two families reported. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.8 | Zornitza Stark Panel types changed to Melbourne Genomics; Victorian Clinical Genetics Services; Rare Disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.7 |
Sebastian Lunke Panel name changed from Susceptibility to viral infections_MelbourneGenomics_VCGS to Susceptibility to Viral Infections Panel types changed to Melbourne Genomics; Victorian Clinical Genetics Services |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.6 | MSN | Zornitza Stark Marked gene: MSN as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.6 | MSN | Zornitza Stark Gene: msn has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.6 | MSN | Zornitza Stark Classified gene: MSN as Green List (high evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.6 | MSN | Zornitza Stark Gene: msn has been classified as Green List (High Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.5 | MSN |
Zornitza Stark gene: MSN was added gene: MSN was added to Susceptibility to viral infections_MelbourneGenomics_VCGS. Sources: Expert list Mode of inheritance for gene: MSN was set to X-LINKED: hemizygous mutation in males, biallelic mutations in females Publications for gene: MSN were set to 27405666 Phenotypes for gene: MSN were set to Immunodeficiency 50, MIM# 300988 Review for gene: MSN was set to GREEN Added comment: Seven males from five unrelated families reported. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.4 | IRF3 | Zornitza Stark Marked gene: IRF3 as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.4 | IRF3 | Zornitza Stark Gene: irf3 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.4 | IRF3 | Zornitza Stark Classified gene: IRF3 as Amber List (moderate evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.4 | IRF3 | Zornitza Stark Gene: irf3 has been classified as Amber List (Moderate Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.3 | IRF3 |
Zornitza Stark gene: IRF3 was added gene: IRF3 was added to Susceptibility to viral infections_MelbourneGenomics_VCGS. Sources: Expert list Mode of inheritance for gene: IRF3 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: IRF3 were set to 26216125; 20660188; 26513235 Phenotypes for gene: IRF3 were set to {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}, MIM# 616532 Penetrance for gene: IRF3 were set to Incomplete Review for gene: IRF3 was set to AMBER Added comment: Two affected individuals reported, reduced penetrance, mouse model. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.1 | Zornitza Stark Panel name changed from Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS to Susceptibility to viral infections_MelbourneGenomics_VCGS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | UNC93B1 |
Zornitza Stark gene: UNC93B1 was added gene: UNC93B1 was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: UNC93B1 was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | TRAF3 |
Zornitza Stark gene: TRAF3 was added gene: TRAF3 was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: TRAF3 was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | TMC8 |
Zornitza Stark gene: TMC8 was added gene: TMC8 was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: TMC8 was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | TMC6 |
Zornitza Stark gene: TMC6 was added gene: TMC6 was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: TMC6 was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | TLR3 |
Zornitza Stark gene: TLR3 was added gene: TLR3 was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: TLR3 was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | TICAM1 |
Zornitza Stark gene: TICAM1 was added gene: TICAM1 was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: TICAM1 was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | TBK1 |
Zornitza Stark gene: TBK1 was added gene: TBK1 was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: TBK1 was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | STAT2 |
Zornitza Stark gene: STAT2 was added gene: STAT2 was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: STAT2 was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | STAT1 |
Zornitza Stark gene: STAT1 was added gene: STAT1 was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: STAT1 was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | IRF7 |
Zornitza Stark gene: IRF7 was added gene: IRF7 was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: IRF7 was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | FCGR3A |
Zornitza Stark gene: FCGR3A was added gene: FCGR3A was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: FCGR3A was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | CXCR4 |
Zornitza Stark gene: CXCR4 was added gene: CXCR4 was added to Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services,Melbourne Genomics Health Alliance Immunology Flagship Mode of inheritance for gene: CXCR4 was set to Unknown |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Susceptibility to Viral Infections v0.0 | Zornitza Stark Added panel Susceptibility to viral infections_MelbourneGenomics_AustralianGenomics_VCGS |